Trial

Phase 1 Escalating Single-dose Safety, Tolerability, and Pharmacokinetics of SQ109 in Healthy Volunteers

Study Director
Start Date
0 / 0
Trial Phase
Trial Status
published
Current Enrollment
62
Target Enrollment
62
Overview
Compound Associations